L. C. Paul

485 total citations
22 papers, 380 citations indexed

About

L. C. Paul is a scholar working on Transplantation, Immunology and Surgery. According to data from OpenAlex, L. C. Paul has authored 22 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Transplantation, 7 papers in Immunology and 6 papers in Surgery. Recurrent topics in L. C. Paul's work include Renal Transplantation Outcomes and Treatments (12 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). L. C. Paul is often cited by papers focused on Renal Transplantation Outcomes and Treatments (12 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). L. C. Paul collaborates with scholars based in Netherlands, Canada and United Kingdom. L. C. Paul's co-authors include J Rádl, R. M. Valentijn, J.J. Haaijman, Hallgrímur Benediktsson, A. Davidoff, A. M. M. Kootte, Michael J. Mihatsch, P Häyry, M. J. S. Dennis and J Jeffery and has published in prestigious journals such as Transplantation, Journal of Immunological Methods and Nephrology Dialysis Transplantation.

In The Last Decade

L. C. Paul

21 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. C. Paul Netherlands 10 210 148 79 49 48 22 380
Kumi Aita Japan 11 126 0.6× 109 0.7× 99 1.3× 26 0.5× 33 0.7× 28 395
Delphine Morel France 11 97 0.5× 97 0.7× 75 0.9× 23 0.5× 36 0.8× 18 368
Sourabh Chand United Kingdom 11 229 1.1× 128 0.9× 104 1.3× 25 0.5× 17 0.4× 16 409
Sophie Lechaton France 9 277 1.3× 132 0.9× 123 1.6× 51 1.0× 57 1.2× 9 634
Gerold Becker Germany 9 124 0.6× 176 1.2× 152 1.9× 10 0.2× 33 0.7× 24 460
A. McLean United Kingdom 10 318 1.5× 139 0.9× 86 1.1× 27 0.6× 28 0.6× 16 508
Barbara Infante Italy 10 135 0.6× 107 0.7× 31 0.4× 46 0.9× 95 2.0× 16 431
Sam So United States 6 106 0.5× 139 0.9× 25 0.3× 18 0.4× 55 1.1× 10 330
Marianne Wigger Germany 11 98 0.5× 83 0.6× 63 0.8× 50 1.0× 67 1.4× 24 505
Naoki Kohei Japan 13 232 1.1× 261 1.8× 102 1.3× 16 0.3× 19 0.4× 37 514

Countries citing papers authored by L. C. Paul

Since Specialization
Citations

This map shows the geographic impact of L. C. Paul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. C. Paul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. C. Paul more than expected).

Fields of papers citing papers by L. C. Paul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. C. Paul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. C. Paul. The network helps show where L. C. Paul may publish in the future.

Co-authorship network of co-authors of L. C. Paul

This figure shows the co-authorship network connecting the top 25 collaborators of L. C. Paul. A scholar is included among the top collaborators of L. C. Paul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. C. Paul. L. C. Paul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sijpkens, Yvo W.J., Marko J.K. Mallat, C. E. H. Siegert, et al.. (2001). Risk factors of cyclosporine nephrotoxicity after conversion from Sandimmune to Neoral.. PubMed. 55(2). 149–55. 10 indexed citations
2.
Paul, L. C.. (2001). Immunologic risk factors for chronic renal allograft dysfunction.. PubMed. 71(11 Suppl). SS17–23. 36 indexed citations
3.
Paul, L. C.. (1997). Antibodies and chronic organ graft rejection.. PubMed. 2(2). 46–52. 6 indexed citations
4.
Kovarik, John M., Edgar A. Mueller, Françoise Richard, et al.. (1996). EVIDENCE FOR EARLIER STABILIZATION OF CYCLOSPORINE PHARMACOKINETICS IN DE NOVO RENAL TRANSPLANT PATIENTS RECEIVING A MICROEMULSION FORMULATION. Transplantation. 62(6). 759–763. 60 indexed citations
5.
Keurs, Henk E.D.J. ter, et al.. (1994). Effect of cyclosporine on myocardial contractility in the rat.. PubMed. 26(5). 2880–2. 1 indexed citations
6.
Paul, L. C., A. Davidoff, & Hallgrímur Benediktsson. (1994). Cardiac allograft atherosclerosis in the rat. The effect of histocompatibility factors, cyclosporine, and an angiotensin-converting enzyme inhibitor.. PubMed. 57(12). 1767–72. 34 indexed citations
7.
Paul, L. C., P Häyry, Marie L. Foegh, et al.. (1993). Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and kidney transplants: joint proposal from the Fourth Alexis Carrel Conference on Chronic Rejection and Accelerated Arteriosclerosis in Transplanted Organs.. PubMed. 25(2). 2022–3. 57 indexed citations
8.
Benediktsson, Hallgrímur, et al.. (1991). Cyclosporine induces glomerular hemodynamic changes in the rat.. PubMed. 51(3). 739–41. 2 indexed citations
9.
Paul, L. C., et al.. (1990). Xenoantibodies in the rat against guinea pig tissues. Transplant International. 3(4). 199–205. 1 indexed citations
10.
Paul, L. C., et al.. (1990). Xenoantibodies in the rat against guinea pig tissues. Transplant International. 3(1). 199–205. 2 indexed citations
11.
Goulmy, Els, et al.. (1989). RENAL TRANSPLANT PATIENTS MONITORED BY THE CELL-MEDIATED LYMPHOLYSIS ASSAY. Transplantation. 48(4). 559–559. 39 indexed citations
12.
Kootte, A. M. M., et al.. (1989). Long-term results of controlled cyclosporine conversion at 3 months after renal transplantation.. PubMed. 21(1 Pt 2). 1585–6. 7 indexed citations
13.
Tanke, Hans J., et al.. (1988). Comparison of the staining of peripheral blood T lymphocytes by various anti-CD8 and HLA-DR monoclonal antibodies. Journal of Immunological Methods. 111(1). 75–82. 1 indexed citations
14.
Kootte, A. M. M., et al.. (1988). RECURRENT HEMOLYTIC UREMIC SYNDROME IN A RENAL TRANSPLANT RECIPIENT AND REVIEW OF THE LEIDEN EXPERIENCE. Transplantation. 45(1). 248–250. 20 indexed citations
15.
Tanke, Hans J., et al.. (1986). COMPARISON OF MONOCLONAL ANTIBODIES USED FOR IMMUNOLOGICAL MONITORING OF RENAL TRANSPLANT RECIPIENTS. Transplantation. 41(4). 442–446. 5 indexed citations
16.
Es, A. van, et al.. (1986). Prognostic value of T lymphocyte subset ratios for renal transplant survival in patients on different immunosuppressive regimens.. PubMed. 65(2). 373–80. 5 indexed citations
17.
Baldwin, W. M., Frans H.J. Claas, M L Westedt, et al.. (1985). IgM immune complexes, lymphocytotoxins, and rheumatoid factors in renal transplant recipients with CMV disease.. PubMed. 92. 9–13. 1 indexed citations
18.
Rádl, J, R. M. Valentijn, J.J. Haaijman, & L. C. Paul. (1985). Monoclonal gammapathies in patients undergoing immunosuppressive treatment after renal transplantation. Clinical Immunology and Immunopathology. 37(1). 98–102. 62 indexed citations
19.
Gebhardt, D. O. E., et al.. (1984). The Immunochemical Determination of Apolipoprotein A, Total Apolipoprotein A-I and ‘Free’ Apolipoprotein A-I in Serum of Patients on Chronic Haemodialysis. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 21(4). 301–305. 16 indexed citations
20.
Rood, J. J. van, G. G. Persijn, L. C. Paul, et al.. (1981). Significant factors influencing kidney graft survival.. PubMed. 13(1 Pt 2). 909–12. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026